 Odonate Therapeutics NASDAQ:ODT was downgraded by investment analysts at BidaskClub from a buy rating to a hold rating in a research report issued on Monday, BidAskClub reports. Separately, Zacks Investment Research downgraded shares of Odonate Therapeutics from a buy rating to a hold rating in a report on Wednesday, July 1st. Shares of NASDAQ ODT ... 